Myostatin-related muscle hypertrophy

From WikiMD's Food, Medicine & Wellnesspedia

Alternate names[edit | edit source]

Muscle hypertrophy syndrome

Definition[edit | edit source]

Myostatin-related muscle hypertrophy is a rare condition characterized by reduced body fat and increased muscle size.

Epidemiology[edit | edit source]

The prevalence of this condition is unknown.

Cause[edit | edit source]

Mutations in the MSTN gene cause myostatin-related muscle hypertrophy. The MSTN gene provides instructions for making a protein called myostatin, which is active in muscles used for movement (skeletal muscles) both before and after birth. This protein normally restrains muscle growth, ensuring that muscles do not grow too large.

Gene mutations[edit | edit source]

Mutations that reduce the production of functional myostatin lead to an overgrowth of muscle tissue.

Inheritance[edit | edit source]

  • Myostatin-related muscle hypertrophy has a pattern of inheritance known as incomplete autosomal dominance.
  • People with a mutation in both copies of the MSTN gene in each cell (homozygotes) have significantly increased muscle mass and strength.
  • People with a mutation in one copy of the MSTN gene in each cell (heterozygotes) also have increased muscle bulk, but to a lesser degree.

Signs and symptoms[edit | edit source]

  • Affected individuals have up to twice the usual amount of muscle mass in their bodies.
  • They also tend to have increased muscle strength.
  • Myostatin-related muscle hypertrophy is not known to cause any medical problems, and affected individuals are intellectually normal.

Diagnosis[edit | edit source]

  • Skeletal muscle size in an individual with myostatin-related muscle hypertrophy is measured by ultrasound examination, DEXA, or MRI.
  • Subcutaneous fat pad thickness is measured by ultrasound or with a caliper.
  • MSTN is the only gene in which mutation is known to cause myostatin-related muscle hypertrophy.

Treatment[edit | edit source]

Myostatin-related muscle hypertrophy is not known to cause medical complications.

[1]

References[edit | edit source]

  1. Wagner KR, Cohen JS. Myostatin-Related Muscle Hypertrophy – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2005 Oct 5 [updated 2013 Jul 3]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. PMID: 20301671.

NIH genetic and rare disease info[edit source]

Myostatin-related muscle hypertrophy is a rare disease.


Myostatin-related muscle hypertrophy Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Deepika vegiraju